nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepyramine—SLC22A5—dilated cardiomyopathy	0.782	1	CbGaD
Mepyramine—SLC22A5—Furosemide—dilated cardiomyopathy	0.209	1	CbGbCtD
Mepyramine—SLC22A4—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00317	0.365	CbGpPWpGaD
Mepyramine—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00215	0.247	CbGpPWpGaD
Mepyramine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00043	0.0495	CbGpPWpGaD
Mepyramine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.000368	1	CrCbGaD
Mepyramine—HRH1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000203	0.0234	CbGpPWpGaD
Mepyramine—SLC22A4—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000195	0.0225	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000171	0.0197	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000165	0.0189	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000138	0.0159	CbGpPWpGaD
Mepyramine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000134	0.0154	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000104	0.0119	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000102	0.0118	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.93e-05	0.0114	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.93e-05	0.0114	CbGpPWpGaD
Mepyramine—HRH1—IL-4 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	9.54e-05	0.011	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.23e-05	0.0106	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.68e-05	0.00884	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.47e-05	0.0086	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.94e-05	0.00799	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	4.35e-05	0.00501	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	4.33e-05	0.00499	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	4.05e-05	0.00466	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	3.92e-05	0.00451	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	3.87e-05	0.00446	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	3.73e-05	0.00429	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	3.73e-05	0.00429	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	3.47e-05	0.00399	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	3.36e-05	0.00387	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	3.35e-05	0.00385	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	3.18e-05	0.00366	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	3.05e-05	0.00351	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	2.87e-05	0.0033	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	2.84e-05	0.00327	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	2.84e-05	0.00327	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	2.73e-05	0.00314	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	2.72e-05	0.00313	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	2.64e-05	0.00304	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	2.56e-05	0.00294	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.18e-05	0.00251	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	2.07e-05	0.00239	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.02e-05	0.00232	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.01e-05	0.00232	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	1.89e-05	0.00218	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.63e-05	0.00188	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.6e-05	0.00185	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.6e-05	0.00185	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	1.54e-05	0.00177	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.54e-05	0.00177	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.51e-05	0.00174	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.49e-05	0.00172	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.46e-05	0.00168	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.46e-05	0.00168	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.45e-05	0.00166	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.39e-05	0.0016	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.35e-05	0.00156	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.31e-05	0.00151	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	1.3e-05	0.00149	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.23e-05	0.00142	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.17e-05	0.00135	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.12e-05	0.00129	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.06e-05	0.00122	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.7e-06	0.00112	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.09e-06	0.00105	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.68e-06	0.001	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.61e-06	0.000991	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.61e-06	0.000991	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.25e-06	0.000951	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8e-06	0.000922	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	7.89e-06	0.000908	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.75e-06	0.000893	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.62e-06	0.000762	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.28e-06	0.000723	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.47e-06	0.00063	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.4e-06	0.000622	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.88e-06	0.000562	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	4.66e-06	0.000537	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.78e-06	0.000435	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.75e-06	0.000432	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.68e-06	0.000423	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.31e-06	0.000381	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.23e-06	0.000372	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.22e-06	0.000255	CbGpPWpGaD
